Abstract: Objective To determine whether sulforaphane (SFN) protects neurons against injury caused by oxygenglucose deprivation/reoxygenation (OGD/R) and, if so, to investigate the possible mechanisms. Methods Primary cultures of neurons were prepared from the cerebral cortex of 1-day-old Sprague-Dawley rats. On days 5-6 in vitro, the neurons were exposed to OGD for 1 h, followed by reoxygenation for 24 h. Cells were treated with 0, 0.1, 0.2, 0.5, 1, 2.5, or 5 µmol/L SFN, with or without 10 µmol/L LY294002, a PI3K-specific inhibitor, during OGD/R (a total of 25 h). After 24-h reoxygenation, MTT was used to assess viability and injury was assessed by Hoechst 33258/propidium iodide (PI) staining; immunofluorescence staining and Western blot were performed to detect molecular events associated with apoptosis.
Introduction
Hypoxic-ischemic brain injury is one of the main causes of disability and death worldwide. The pathophysiology involves multiple biochemical mechanisms such as the generation of reactive oxygen species, glutamatemediated excitotoxicity, inflammation and apoptosis [1] . One of the central mechanisms of hypoxic-ischemic brain injury is neuronal loss caused by apoptosis [2, 3] . The Bcl-2 family and caspases play key roles in the apoptotic cascade [4] . A primary cell survival pathway, the PI3K/Akt pathway, has been shown to promote cell survival and inhibit apoptosis by phosphorylating and inhibiting apoptosis-induced proteins [5, 6] .
Sulforaphane (SFN), a naturally-occurring isothiocyanate, is found in cruciferous vegetables such as broccoli. It has been shown to be neuroprotective in models of hypoxic-ischemic brain injury [1, 7, 8] . SFN has various pharmacological actions, such as anti-inflammatory [9] [10] [11] , antioxidant [12, 13] , anti-apoptotic [14] , and anti-cancer [15, 16] effects.
Moreover, a previous study showed that dietary use of SFN can decrease aging-related degenerative changes [17] . These cells/well. The cells were maintained at 37ºC in a humidified incubator (Thermo3111, Waltham, MA) containing 5% CO 2 and 95% air. After 24 h, the medium was changed to fresh neurobasal medium (Gibco) supplemented with 2% B27 (Gibco) and 1% penicillin/streptomycin, then refreshed every 3 days throughout the study. Under these conditions, this serum-free culture contained ~90% neurons as determined by NeuN and Hoechst 3258 staining.
Experiments were performed at 5-6 days in vitro.
OGD/R application OGD was performed according
to a previously described method [20, 21] . In brief, the culture medium was removed and cells were washed twice with glucose-free DMEM (Gibco). To initiate OGD, glucosefree DMEM was added to cultures which were immediately transferred to a chamber (Thermo3131, Waltham, MA)
with an atmosphere of 94% N 2 , 1% O 2 and 5% CO 2 at 37ºC.
OGD was terminated after 1 h by replacing the glucosefree DMEM with neurobasal medium supplemented with 2% B27 and the cultures were further incubated under 95% air and 5% CO 2 for 24 h at 37ºC. Cells in the control group were treated identically except that they were not exposed to OGD. and OGD/R groups were given equal volumes of medium.
Drug treatment

Cell viability assay
Viability was assessed by the MTT (Sigma) assay. The assay is based on the ability of living cells to convert dissolved yellow MTT into insoluble purple formazan [22] . After OGD/R, MTT was added to a final concentration of 0.5 mg/mL and the cells were maintained in a humidified incubator under 5% CO 2 and 95% air for 4 h at 37ºC. After incubation, the medium was removed and 150 μL DMSO was added to dissolve the formazan product into a solution which was read at 490 nm using a microplate reader (Thermo1500, Waltham, MA).
The absorbance of the formazan formed in control cells was taken as 100% viability. software. β-actin was used as an internal control.
Hoechst and propidium iodide (PI) staining
Statistical analysis
All data are presented as mean ± SEM. Statistical differences among the various groups
were assessed with one-way ANOVA followed by a post hoc test. Comparisons between two groups were assessed by the unpaired t-test. Data were analyzed using SPSS 17.0 software. P <0.05 was considered as statistically significant.
Results
SFN increases cell viability on exposure to OGD/R
NeuN and Hoechst 3258 staining showed that the cultured cells were ~90% neurons (Fig. 1) . MTT assays showed that maximal neuroprotection occurred at 1 µmol/L SFN ( Fig.   2A ), so we chose this dose for subsequent experiments.
Viability was markedly decreased in the OGD/R group (37.5 ± 9.4%, P <0.01 vs control 100%). SFN increased the viability (54.6 ± 8.8%, P <0.01 vs OGD/R; P <0.05 vs SFN+LY 40.8 ± 7.9%; P <0.01 vs LY 36.9 ± 7.5%) (Fig.   2B ). We found that LY294002 alone had no adverse or protective effect (P >0.05 vs OGD/R). Therefore, LY294002
alone was not used in subsequent experiments.
SFN decreases cell injury caused by OGD/R Cell
death was assessed by Hoechst33258/PI staining; Hoechst 33258 stained all nuclei, and PI-positive cells with condensed blue nuclei were considered to be dead/dying cells (Fig. 3A) . The percentage of dead cells was considerably increased by exposure to OGD/R (61.5 ± 9.3%, P <0.01
vs control 1.0 ± 0.5%), while SFN decreased the percentage (42.3 ± 7.8%, P <0.01 vs OGD/R, P <0.05 vs SFN+LY 57.7 ± 8.7%) (Fig. 3B ). 63.3 ± 7.6%, P <0.01 vs OGD/R 26.9 ± 8.5%; P < 0.01 vs SFN+LY 34.6 ± 7.9%) and Western blot ( Fig. 5A, B ; optical density, 0.75 ± 0.08, P <0.01 vs OGD/R 0.57 ± 0.07; P <0.01 vs SFN+LY 0.54 ± 0.09). Moreover, the level of cleaved caspase-3 increased remarkably in the OGD/R group, but SFN decreased it according to immunofluorescence staining (Fig. 4B, D; 31.2 ± 8.3%, P <0.01 vs OGD/R 51.1 ± 9.6%; P <0.01 vs SFN+LY 59.1 ± 7.8%) and
Western blot (Fig. 5C, D; optical density, 0.41 ± 0.06, P <0.01 vs OGD/R 0.67 ± 0.09; P <0.01 vs SFN+LY 0.92 ± 0.04).
Effect of PI3K/Akt pathway in SFN-mediated
anti-apoptosis We then explored whether SFN prevents apoptosis by activating the PI3K/Akt pathway. The MTT assay showed that viability decreased in the group treated with LY294002 and SFN ( Fig. 2B ; 40.8 ± 7.9%, P <0.05
vs SFN 54.6 ± 8.8%). The MTT results were further confirmed by Hoechst 33258/PI staining (Fig. 3A, B) , which showed that LY294002 with SFN increased the number of dead cells (57.7 ± 8.7%, P <0.05 vs SFN 42.3 ± 7.8%).
We also found that LY294002 with SFN decreased the expression of Bcl-2 and increased the expression of cleaved caspase-3 compared with the SFN group by immunofluorescence staining (Fig. 4) and Western blot analysis (Fig.   5 ). We then assessed the signaling molecules Akt and p-Akt by Western blot, and found that p-Akt was increased in the SFN group (optical density, 0.70 ± 0.10, P <0.01 vs OGD/R 0.50 ± 0.07; P <0.01 vs SFN+LY 0.35 ± 0.09). However, p-Akt was significantly inhibited by LY294002. In addition,
we found that the total Akt expression did not differ among the groups (Control 0.86 ± 0.11, OGD/R 0.99 ± 0.05, SFN 0.92 ± 0.08, SFN+LY 0.88 ± 0.10; P >0.05) (Fig. 6 ).
These observations indicated that SFN prevented hypoxicischemic brain injury and this neuroprotective effect could be related to the activation of the PI3K/Akt pathway.
Discussion
In the present study, we found that treatment with SFN was neuroprotective in OGD/R and explored its mecha- It protects the brain against hypoxic-ischemic injury by inducing Nrf2-dependent phase 2 enzyme [8] and the bloodbrain barrier after brain injury by increasing the expression of Nrf2-driven genes in vivo [23] . It also protects immature hippocampal neurons by activating the ARE/Nrf2 pathway in vitro [13] . However, the mechanism of SFN-mediated protection against ischemic brain injury needs further clarification.
To further clarify the relationship between apoptosis and the effect of SFN in primary cultured cortical neurons exposed to OGD/R, we tested the effect of SFN on molecular events related to apoptosis. Bcl-2 family members are the arbiters of the mitochondrial apoptotic pathway and decide whether a cell lives or dies [24] . This family includes anti-apoptotic and pro-apoptotic genes [25] . Bcl-2, an inhibitor of apoptosis, prevents neuronal apoptosis by blocking the destruction of mitochondria and the subsequent release of cytochrome c and caspase activation [26] . Under the condition of hypoxic-ischemic brain injury, the outer membrane of mitochondria becomes permeable [27] , which leads to the release of cytochrome c and further promotes the activation of caspase-3, a key mediator of apoptosis [28] [29] [30] [31] . It is activated by cleavage, and active caspase-3 leads to DNA fragmentation and eventually apoptosis [32, 33] . We found that 1 µmol/L SFN increased the level of anti-apoptotic Bcl-2 and decreased the level of cleaved caspase-3. These results suggested that one of the mechanisms of action of SFN against injury by OGD/R could be partly related to its antiapoptotic effects.
It is well known that activation of the PI3K/Akt pathway is important for neuronal survival. Recent studies found that the PI3K/Akt pathway is involved in the upregulation of HIF-1α which plays important roles in neuroprotection after hypoxic-ischemic injury [34] . Decreased Akt activity caused by ischemia or hypoxia can lead to neuronal death [35] . In contrast, increased Akt activity can contribute to neuronal survival. Therefore, we investigated the role of the PI3K/Akt pathway in SFN-mediated anti-apoptosis after OGD/R. p-Akt is necessary for Akt activation. To further explore the neuroprotective mechanism of SFN, we assessed the expression of p-Akt. The results showed that SFN significantly increased the expression of p-Akt, but this was significantly inhibited by LY294002. These results
suggest that SFN provides neuronal protection by activating the PI3K/Akt pathway.
In summary, our study demonstrated that SFN was neuroprotective against injury caused by OGD/R and this effect could be mediated by anti-apoptosis. These results suggest that SFN may be a promising agent against hypoxicischemic brain injury. 
